Drug Profile


Alternative Names: Anboxan; S 1452

Latest Information Update: 29 May 2001

Price : $50 *
* Final gross price and currency may vary according to local VAT and billing address.
* Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase. A link to download a PDF version of the drug profile will be included in your email receipt. Adis is an information provider. We do not sell or distribute the pharmaceutical compounds written about in this database.

At a glance

  • Originator Shionogi
  • Class Antiallergics
  • Mechanism of Action Thromboxane A2 receptor antagonists
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.


Highest Development Phases

  • Discontinued Allergic rhinitis; Arterial thrombosis; Asthma; Coronary thrombosis; Intracranial thrombosis

Most Recent Events

  • 29 May 2001 Discontinued-II for Allergic rhinitis in Japan (PO)
  • 29 May 2001 Discontinued-preregistration for Asthma in Japan (PO)
  • 30 Jun 1998 Discontinued-Unspecified phase in Arterial thrombosis in Japan (PO)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at so we can help.

Back to top